February Announcements On UK’s Medtech Regulatory System Change Awaited
UKCA regulatory update from industry: January 2023
Much preparation work is underway among industry and the authorities as the UK seeks to nail down what kind of medtech regulatory system it wants for the future. Hosting an update session were the ABHI’s Phil Brown and Steve Lee.
You may also be interested in...
The Life Sciences Council has agreed to issue proposals on how the UK should recognize approvals granted by other trusted medical device regulatory jurisdictions. The need for speed in all matters relating to the UK’s sovereign medtech regulatory system has been stressed by the UK devices industry.
Architects of the major reform of secondary care reimbursement have asked for the input of hospitals just once, the DKG hospital federation complains. Meanwhile, many clinics are reportedly facing insolvency later this year.
BD and Boston Scientific exemplify the approach of “big medtech” as it knuckles down to meet global climate change responsibilities. But the industry will have to work together with health systems to achieve the larger race to zero goals – especially those of scope 3.